U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Single Specialty Labs, Hybrid Labs), By Service, By Specialist, And Segment Forecasts, 2020 - 2027

U.S. Office-based Labs Market Growth Growth & Trends Trends

The U.S. office-based labs market size is expected to reach USD 14.5 billion by 2027, according to aew report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.06% from 2020 to 2027. Increasing prevalence of target diseases and rising preference for minimally invasive procedures in outpatient settings are the major factors driving the demand for office-based labs (OBL) in the U.S. High prevalence of risk factors such as smoking, high blood pressure, diabetes, and high cholesterol, in combination with the growing geriatric population, is expected to increase the incidence of peripheral artery diseases (PADs). The resultant surge in theumber of procedures performed for their treatment is anticipated to fuel the market growth during the forecast period.

More than 250 million people worldwide suffer from peripheral artery diseases and their prevalence increased by 24% between 2000 and 2010. The trend is expected to continue over the coming years. Low-income countries witnessed a 29% growth in theumber of individuals suffering from PADs in the past decade, while high-income countries witnessed a growth of 13%. PADs increase the risk of stroke and heart attack and often lead to ischemic amputations. According to an estimation, 150,000 cases of ischemic amputations are recorded every year in the U.S. alone.

Many service providers such asational Cardiovascular Partners, Envision Healthcare, and Surgery Partners are available in the U.S., providing services related to office-based surgery to patients at an affordable cost.

Early in the pandemic, theumber of visits to ASCs and any other outpatient facilities, such as OBLs, declined. During this period, the visit count increased for telemedicine. It increased rapidly in the mid-April and slightly declined in the last weeks. But with the COVID-19 phase 2 reopening, a rebound in visits is witnessed in all areas of the U.S. As most of the ASCs and OBL operate on the fee-for-service model, a decline in theumber of visits directly impacted the income of the facilities. Few OBLs have started operations and are following all the guidelines set by the state and local officials.

U.S. Office-based Labs Market Report Highlights

By modality, single-specialty OBLs spearheaded the market in 2019. Hybrid office-based labs are anticipated to witness high growth during the forecast period. Single-specialty labs offer more patient-centric treatments while hybrid models offer more profitability with multiple facilities under one roof

In terms of service, peripheral vascular intervention (PVI) dominated the U.S. market in 2019 owing to a high prevalence of atherosclerosis in the country. A largeumber of balloon angioplasty and stenting procedures being performed in patients with blocked arteries and veins has also aided the segment growth

By specialist, vascular surgeons are the leading service providers in OBLs and held the largest share in 2019. This is attributed to the rising burden of vascular diseases in the country. All the major vascular surgeries such as aortic, mesenteric, renal, subclavian, iliofemoral, tibia, and pedal are being performed by vascular surgeons in office settings

In the U.S. almost 70% of surgical procedures are performed in outpatient settings, out of which, around 25% are performed in a physician’s office

Mergers and acquisitions, technological advancements, andew product launches are some of the strategies followed by major players in the market. In August 2019, Boston Scientific acquired BTG PLC to expand its portfolio of minimally invasive surgical devicesPlease note: The report will be updated with the latest data and delivered to you within 2-3 business days.


Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Modality
1.1.2 Service
1.1.3 Specialist
1.1.4 Country Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Volume Price Analysis (Model 1.1)
1.6.2 Volume Price Analysis (Model 1.2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Service
2.2.3 Specialist
2.3 Competitive Insights
Chapter 3 U.S. Office-based Labs (OBLs) Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 U.S. Office-based Labs (OBLs) Market: Penetration & Growth Prospect Mapping
3.3 Market Lineage Outlook
3.3.1 Parent Market
3.3.2 Related/Ancillary Market
3.4 U.S. Office-based Labs (OBLs) Market: Regulatory Framework & Reimbursement Scenario
3.4.1 U.S. Office-based Labs (OBLs) Market: Regulatory Framework
3.4.2 U.S. Office-based Labs (OBLs) Market: Reimbursement Scenario
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing prevalence of target diseases
3.5.1.2 Preference for minimally invasive procedures
3.5.2 Market Restraint Analysis
3.5.2.1 High-risk option for severe cases
3.5.2.2 Lack of technical training for the MIS procedure
3.5.3 Industry Opportunities
3.5.3.1 Approval of endovascular procedures in office-based labs
3.5.3.2 Flexibility for physicians to convert to OBLs
3.6 Business Environment Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 PESTEL Analysis
3.7 Qualitative Analysis: Impact of COVID-19 on Office-based Labs (OBLs)
Chapter 4 U.S. Office-based Labs (OBLs) Market: Modality Analysis
4.1 U.S. Office-based Labs (OBLs) Modality Market Share Analysis, 2019 & 2027
4.2 U.S. Office-based Labs (OBLs) Modality Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Modality Segment
4.3.1 Single Specialty Labs
4.3.1.1 Single specialty labs market, 2016 - 2027 (USD Million)
4.3.2 Multi-specialty Labs
4.3.2.1 Multi-specialty labs market, 2016 - 2027 (USD Million)
4.3.3 Hybrid Labs
4.3.3.1 Hybrid labs market, 2016 - 2027 (USD Million)
4.3.3.2 Qualitative analysis: Future trends of hybrid labs
Chapter 5 U.S. Office-based Labs (OBLs) Market: Service Analysis
5.1 U.S. Office-based Labs (OBLs) Service Market Share Analysis, 2019 & 2027
5.2 U.S. Office-based Labs (OBLs) Service Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Service Segment
5.3.1 Peripheral Vascular Intervention
5.3.1.1 Peripheral vascular intervention market, 2016 - 2027 (USD Million)
5.3.2 Endovascular Interventions
5.3.2.1 Endovascular interventions market, 2016 - 2027 (USD Million)
5.3.3 Cardiac
5.3.3.1 Cardiac market, 2016 - 2027 (USD Million)
5.3.4 Interventional Radiology
5.3.4.1 Interventional radiology market, 2016 - 2027 (USD Million)
5.3.5 Venous
5.3.5.1 Venous market, 2016 - 2027 (USD Million)
5.3.6 Others
5.3.6.1 Others market, 2016 - 2027 (USD Million)
Chapter 6 U.S. Office-based Labs (OBLs) Market: Specialist Analysis
6.1 U.S. Office-based Labs (OBLs) Specialist Market Share Analysis, 2019 & 2027
6.2 U.S. Office-based Labs (OBLs) Specialist Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Specialist Segment
6.3.1 Vascular Surgeons
6.3.1.1 Vascular surgeons market, 2016 - 2027 (USD Million)
6.3.2 Interventional Cardiologists
6.3.2.1 Interventional cardiologists market, 2016 - 2027 (USD Million)
6.3.3 Interventional Radiologists
6.3.3.1 Interventional radiologists market, 2016 - 2027 (USD Million)
6.3.4 Other Specialists
6.3.4.1 Other specialists market, 2016 - 2027 (USD Million)
Chapter 7 U.S. Office-based Labs (OBLs) Market: Regional Analysis
7.1 U.S. Office-based Labs (OBLs) Market, 2016 - 2027 (USD Million)
7.2 U.S Office-based Labs (OBLs) Market: Top 5 States
7.2.1 Penetration Analysis: Top 5 States 2019
7.3 Pricing Analysis
7.3.1 Average Cost of Major Procedures Performed in Office-based Labs
7.3.2 Average Cost of Major Devices Used in Office-based Labs
7.3.3 Average Cost of Setting up an Office-based Lab
Chapter 8 Competitive Analysis
8.1 Vendor Landscape
8.1.1 Partnerships
8.1.2 Marketing & Promotions
8.2 Suppliers
8.2.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2.2 Strategic Framework/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.2.3 Market Position Analysis: Imaging Devices Manufacturer
8.2.4 Market Position Analysis: Vascular Intervention Devices
8.3 Service Providers
8.3.1 Market Position Analysis
8.4 Suppliers Company Profiles
8.4.1 Koninklijke Philips N.V.
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.1.5 SWOT analysis
8.4.2 GE Healthcare
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.2.5 SWOT analysis
8.4.3 Siemens Healthineers
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.3.5 SWOT analysis
8.4.4 Medtronic PLC
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.4.5 SWOT analysis
8.4.5 Boston Scientific Corporation
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.5.5 SWOT analysis
8.4.6 Abbott
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.6.5 SWOT analysis
8.4.7 Cardiovascular Systems, Inc.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.7.5 SWOT analysis
8.5 Service Providers Company Profiles
8.5.1 Envision Healthcare Corporation
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Service benchmarking
8.5.1.4 Strategic initiatives
8.5.1.5 SWOT Analysis
8.5.2 Surgical Care Affiliates (SCA)
8.5.2.1 Company overview
8.5.2.2 Financial performance
8.5.2.3 Service benchmarking
8.5.2.4 Strategic initiatives
8.5.2.5 SWOT Analysis
8.5.3 Tenet Healthcare Corporation
8.5.3.1 Company overview
8.5.3.2 Financial performance
8.5.3.3 Service benchmarking
8.5.3.4 Strategic initiatives
8.5.3.5 SWOT Analysis
8.5.4 National Cardiovascular Partners, LP
8.5.4.1 Company overview
8.5.4.2 Service benchmarking
8.5.5 Surgery Partners
8.5.5.1 Company overview
8.5.5.2 Financial performance
8.5.5.3 Service benchmarking
8.5.5.4 Strategic Initiatives
8.5.5.5 SWOT Analysis
8.5.6 Cardiovascular Coalition
8.5.6.1 Company overview
8.5.6.2 Service benchmarking
Chapter 9 Recommendations
9.1 KOL Commentary
9.2 Recommendations
Chapter 10 Research Methodology & Scope
10.1 Research Methodology
10.1.1 Information Procurement
10.1.1.1 Purchased database
10.1.1.2 GVR’s internal database
10.1.2 Primary Research
10.2 Research Scope and Assumptions
10.3 List to Data Sources
Chapter 11 Report FAQs
11.1 How do I trust your report quality/data accuracy?
11.2 My research requirement is very specific; can I customize this report?
11.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
11.4 How do you arrive at these market numbers?
11.5 Who are your clients?
11.6 How will I receive this report?
Chapter 12 Appendix
Chapter 13 Compass - Cloud-based Report Delivery Platform
Chapter 14 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook